InnateDB Protein
|
IDBP-58708.5
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
FOXL2
|
Protein Name
|
forkhead box L2
|
Synonyms
|
BPES; BPES1; PFRK; PINTO; POF3;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000333188
|
InnateDB Gene
|
IDBG-58706 (FOXL2)
|
Protein Structure
|
|
Function |
Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans- differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2. {ECO:0000250, ECO:0000269PubMed:16153597, ECO:0000269PubMed:19010791, ECO:0000269PubMed:19429596, ECO:0000269PubMed:19744555}.
|
Subcellular Localization |
Nucleus {ECO:0000255PROSITE- ProRule:PRU00089, ECO:0000269PubMed:19744555}.
|
Disease Associations |
Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]: A disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold curving in the mediolateral direction, inferior to the inner canthus. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects. {ECO:0000269PubMed:11175783, ECO:0000269PubMed:11468277, ECO:0000269PubMed:12400065, ECO:0000269PubMed:12529855, ECO:0000269PubMed:12630957, ECO:0000269PubMed:12938087, ECO:0000269PubMed:15257268, ECO:0000269PubMed:16454982, ECO:0000269PubMed:17089161, ECO:0000269PubMed:18484667, ECO:0000269PubMed:18642388, ECO:0000269Ref.2}. Note=The disease is caused by mutations affecting the gene represented in this entry. There is a mutational hotspot in the region coding for the poly-Ala domain, since 30% of all mutations in the ORF lead to poly-Ala expansions, resulting mainly in BPES type II.Premature ovarian failure 3 (POF3) [MIM:608996]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269PubMed:12149404, ECO:0000269PubMed:19429596}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
In addition to its expression in the developing eyelid, it is transcribed very early in somatic cells of the developing gonad (before sex determination) and its expression persists in the follicular cells of the adult ovary.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 7 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated |
Total |
7
[view]
|
Protein-Protein |
7
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
3 [view]
|
|
|
Molecular Function |
Accession |
GO Term |
GO:0003677
|
DNA binding
|
GO:0003700
|
sequence-specific DNA binding transcription factor activity
|
GO:0005515
|
protein binding
|
GO:0030331
|
estrogen receptor binding
|
GO:0031624
|
ubiquitin conjugating enzyme binding
|
GO:0043028
|
cysteine-type endopeptidase regulator activity involved in apoptotic process
|
GO:0043565
|
sequence-specific DNA binding
|
|
Biological Process |
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
GO:0001541
|
ovarian follicle development
|
GO:0002074
|
extraocular skeletal muscle development
|
GO:0006309
|
apoptotic DNA fragmentation
|
GO:0006355
|
regulation of transcription, DNA-templated
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
GO:0019101
|
female somatic sex determination
|
GO:0030154
|
cell differentiation
|
GO:0042703
|
menstruation
|
GO:0043065
|
positive regulation of apoptotic process
|
GO:0043280
|
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
GO:0045892
|
negative regulation of transcription, DNA-templated
|
GO:0045893
|
positive regulation of transcription, DNA-templated
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
GO:0048048
|
embryonic eye morphogenesis
|
GO:0060014
|
granulosa cell differentiation
|
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR001766
Transcription factor, fork head
|
PFAM |
PF00250
|
PRINTS |
PR00053
|
PIRSF |
|
SMART |
SM00339
|
TIGRFAMs |
|
Modification |
|
SwissProt |
P58012
|
PhosphoSite |
PhosphoSite-P58012
|
TrEMBL |
Q53ZD3
|
UniProt Splice Variant |
|
Entrez Gene |
668
|
UniGene |
Hs.614426
|
RefSeq |
NP_075555
|
HUGO |
HGNC:1092
|
OMIM |
605597
|
CCDS |
CCDS3105
|
HPRD |
05723
|
IMGT |
|
EMBL |
AF301906
AY331134
BC062549
DQ016593
DQ016608
DQ016609
DQ089670
DQ089672
|
GenPept |
AAH62549
AAK01352
AAQ01519
AAY21821
AAY21822
AAY21823
AAY89234
AAY89236
|
|
|